Prof. Massimo Cristofanilli shares his perspective on the future of liquid biopsy, the complementary purposes of CTC and cfDNA technologies, and when one should expect clinical utility of liquid biopsies.

For more information, please visit http://www.NextGenerationDx.com/Circulating-Tumor-Cells/

Prof. Massimo Cristofanilli shares his perspective on the future of liquid biopsy, the complementary purposes of CTC and cfDNA technologies, and when one should expect clinical utility of liquid biopsies. For more information, please visit http://www.NextGenerationDx.com/Circulating-Tumor-Cells/

Next Generation Dx 2018 | Dissecting Liquid Biopsy in MBC

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.

Share Next Generation Dx 2018 | Dissecting Liquid Biopsy in MBC

Sign up to save your podcasts

Next Generation Dx 2018 | Dissecting Liquid Biopsy in MBC

Next Generation Dx 2018 | Dissecting Liquid Biopsy in MBC